3rd Annual mRNA-Based Therapeutics Summit
| When | Tuesday, January 23, 2024 - Thursday, January 25, 2024 |
| Where | Berlin Germany |
| Location | |
| Organised by | Hanson Wade |
| Number of Attendees | 250 |
| Share this page: |  |
 |
 |
 |
About the event
The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe’s largest and most important gathering of mRNA experts.
Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 250+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R&D and pipeline expansions.
The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe’s largest and most important gathering of mRNA experts.
Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 250+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R&D and pipeline expansions.
Key Themes
- Unlock European-specific regulatory expectations for mRNA therapeutics and vaccines to ensure compliance, identify potential risks and enable patient access to your drugs without delays
- Overcome safety, PK/PD and translational hurdles to accelerate a surge of pre-clinical mRNA-based therapeutic candidates into robust clinical pipelines with emphasis on improving the efficiency and success of your drugs
- Improve drug delivery vehicle design and molecule characterisation to overcome immunogenicity and thermostability hurdles
- Maintain momentum in mRNA mergers and acquisitions, partnerships and investments in Europe and beyond to fuel the next generation of breakthroughs, reduce cost of goods and ensure R&D success beyond COVID-19
What's New
| Attendees: | 250+ |
| World-Class Speakers: | 40+ |
| Hours of Networking: | 10+ |
| Tracks of Content: | 2 |
| Pre-Conference AI Focus Day: | 1 |
| Pre-Conference Workshop Day: | 1 |
| Interactive Panel Discussions: | 4 |